title: Canadian hand dermatitis management guidelines.
abstract: BACKGROUND
  Hand dermatitis (HD) is one of the most common skin conditions; however, it is not a homogeneous disease entity. The severity of HD may range from very mild cases to severe chronic forms, which may result in prolonged disability and, occasionally, refractory HD. Chronic hand dermatitis (CHD) is associated with a high health- economic burden and significant loss of quality of life.
  
  
  OBJECTIVE
  Although numerous treatment options are available, the management of CHD is often difficult and unsatisfactory. There is a paucity of well-designed, randomized, controlled clinical trials in support of the efficacy of established treatment modalities.
  
  
  CONCLUSIONS
  These guidelines cover the epidemiology, burden, quality of life, etiology, diagnosis, classification, and prevention of HD and provide guidance on management using an approach that is as evidence based as possible.
authors.forename: Charles
authors.initials: C
authors.lastname: Lynde
authors.forename: Lyn
authors.initials: L
authors.lastname: Guenther
authors.forename: Thomas L
authors.initials: TL
authors.lastname: Diepgen
authors.forename: Denis
authors.initials: D
authors.lastname: Sasseville
authors.forename: Yves
authors.initials: Y
authors.lastname: Poulin
authors.forename: Wayne
authors.initials: W
authors.lastname: Gulliver
authors.forename: Tove
authors.initials: T
authors.lastname: Agner
authors.forename: Kirk
authors.initials: K
authors.lastname: Barber
authors.forename: Robert
authors.initials: R
authors.lastname: Bissonnette
authors.forename: Vincent
authors.initials: V
authors.lastname: Ho
authors.forename: Neil H
authors.initials: NH
authors.lastname: Shear
authors.forename: Jack
authors.initials: J
authors.lastname: Toole
mesh_terms: D002170:Canada; D017281:Cost of Illness; D003879:Dermatologic Agents / Q000627:therapeutic use; D006229:Hand Dermatoses / Q000175:diagnosis* / Q000209:etiology / Q000628:therapy*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D010789:Phototherapy; D017410:Practice Guidelines as Topic; D011788:Quality of Life
chemical_list: D003879:Dermatologic Agents; D007166:Immunosuppressive Agents